nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—ALOX5—Synthesis of 5-eicosatetraenoic acids—GPX1—dilated cardiomyopathy	0.0321	0.0655	CbGpPWpGaD
Aminosalicylic Acid—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.0284	0.0572	CcSEcCtD
Aminosalicylic Acid—PLA2G2E—Phospholipid metabolism—TAZ—dilated cardiomyopathy	0.0272	0.0554	CbGpPWpGaD
Aminosalicylic Acid—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0255	0.0513	CcSEcCtD
Aminosalicylic Acid—Eruption—Furosemide—dilated cardiomyopathy	0.022	0.0443	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Furosemide—dilated cardiomyopathy	0.0139	0.0279	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.013	0.0261	CcSEcCtD
Aminosalicylic Acid—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.0111	0.0225	CbGpPWpGaD
Aminosalicylic Acid—Vascular purpura—Furosemide—dilated cardiomyopathy	0.011	0.0221	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0109	0.0219	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.0104	0.0209	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Lisinopril—dilated cardiomyopathy	0.0104	0.0209	CcSEcCtD
Aminosalicylic Acid—Purpura—Furosemide—dilated cardiomyopathy	0.0102	0.0205	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00973	0.0196	CcSEcCtD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.0093	0.019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—NPPB—dilated cardiomyopathy	0.0092	0.0188	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00875	0.0178	CbGpPWpGaD
Aminosalicylic Acid—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00869	0.0175	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00855	0.0172	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00816	0.0164	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00766	0.0154	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00755	0.0152	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00706	0.0142	CcSEcCtD
Aminosalicylic Acid—Urticaria—Spironolactone—dilated cardiomyopathy	0.00705	0.0142	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00701	0.0141	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00671	0.0135	CcSEcCtD
Aminosalicylic Acid—Droxidopa—ADRB1—dilated cardiomyopathy	0.00669	0.543	CrCbGaD
Aminosalicylic Acid—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00666	0.0134	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00654	0.0132	CcSEcCtD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.00644	0.0131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—PSEN1—dilated cardiomyopathy	0.00628	0.0128	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00607	0.0122	CcSEcCtD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—NPPA—dilated cardiomyopathy	0.00598	0.0122	CbGpPWpGaD
Aminosalicylic Acid—Malnutrition—Furosemide—dilated cardiomyopathy	0.00591	0.0119	CcSEcCtD
Aminosalicylic Acid—ALOX5—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00589	0.012	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Spironolactone—dilated cardiomyopathy	0.00587	0.0118	CcSEcCtD
Aminosalicylic Acid—Flatulence—Furosemide—dilated cardiomyopathy	0.00583	0.0117	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00579	0.0117	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00576	0.0116	CcSEcCtD
Aminosalicylic Acid—Vomiting—Spironolactone—dilated cardiomyopathy	0.00564	0.0114	CcSEcCtD
Aminosalicylic Acid—Droxidopa—ADRB2—dilated cardiomyopathy	0.00562	0.457	CrCbGaD
Aminosalicylic Acid—Rash—Spironolactone—dilated cardiomyopathy	0.00559	0.0113	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00559	0.0112	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00557	0.0112	CcSEcCtD
Aminosalicylic Acid—Headache—Spironolactone—dilated cardiomyopathy	0.00556	0.0112	CcSEcCtD
Aminosalicylic Acid—Jaundice—Lisinopril—dilated cardiomyopathy	0.00554	0.0111	CcSEcCtD
Aminosalicylic Acid—Anaemia—Furosemide—dilated cardiomyopathy	0.00547	0.011	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.0053	0.0107	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Furosemide—dilated cardiomyopathy	0.00529	0.0107	CcSEcCtD
Aminosalicylic Acid—Nausea—Spironolactone—dilated cardiomyopathy	0.00527	0.0106	CcSEcCtD
Aminosalicylic Acid—MPO—Folate Metabolism—SOD2—dilated cardiomyopathy	0.00524	0.0107	CbGpPWpGaD
Aminosalicylic Acid—Hepatitis—Lisinopril—dilated cardiomyopathy	0.0051	0.0103	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00503	0.0101	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.005	0.0101	CcSEcCtD
Aminosalicylic Acid—MPO—Folate Metabolism—GPX1—dilated cardiomyopathy	0.005	0.0102	CbGpPWpGaD
Aminosalicylic Acid—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.005	0.0101	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00473	0.00953	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00473	0.00951	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Furosemide—dilated cardiomyopathy	0.00469	0.00944	CcSEcCtD
Aminosalicylic Acid—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FASLG—dilated cardiomyopathy	0.00464	0.00945	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Osteopontin-mediated events—RAC1—dilated cardiomyopathy	0.00461	0.00939	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Furosemide—dilated cardiomyopathy	0.0046	0.00926	CcSEcCtD
Aminosalicylic Acid—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FAS—dilated cardiomyopathy	0.00447	0.00911	CbGpPWpGaD
Aminosalicylic Acid—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00444	0.00893	CcSEcCtD
Aminosalicylic Acid—CHUK—FAS (CD95) signaling pathway—FASLG—dilated cardiomyopathy	0.00442	0.00901	CbGpPWpGaD
Aminosalicylic Acid—Flatulence—Lisinopril—dilated cardiomyopathy	0.00437	0.0088	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00435	0.00875	CcSEcCtD
Aminosalicylic Acid—CHUK—FAS (CD95) signaling pathway—FAS—dilated cardiomyopathy	0.00426	0.00869	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—NPPA—dilated cardiomyopathy	0.00426	0.00868	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Furosemide—dilated cardiomyopathy	0.0042	0.00844	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00417	0.00839	CcSEcCtD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00416	0.00848	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—ANKRD1—dilated cardiomyopathy	0.00414	0.00844	CbGpPWpGaD
Aminosalicylic Acid—Anaemia—Lisinopril—dilated cardiomyopathy	0.0041	0.00825	CcSEcCtD
Aminosalicylic Acid—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.00404	0.00823	CbGpPWpGaD
Aminosalicylic Acid—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00397	0.00799	CcSEcCtD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00397	0.00809	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00395	0.00794	CcSEcCtD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00393	0.00801	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—TAZ—dilated cardiomyopathy	0.0039	0.00794	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Interleukin-11 Signaling Pathway—RPS6KB1—dilated cardiomyopathy	0.00385	0.00785	CbGpPWpGaD
Aminosalicylic Acid—Urticaria—Furosemide—dilated cardiomyopathy	0.00383	0.00772	CcSEcCtD
Aminosalicylic Acid—CHUK—PDGF Pathway—RAC1—dilated cardiomyopathy	0.00383	0.00781	CbGpPWpGaD
Aminosalicylic Acid—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00382	0.00768	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00382	0.00768	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00375	0.00755	CcSEcCtD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00375	0.00764	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NOD pathway—RAC1—dilated cardiomyopathy	0.00368	0.00751	CbGpPWpGaD
Aminosalicylic Acid—CHUK—FoxO family signaling—SOD2—dilated cardiomyopathy	0.00365	0.00743	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00365	0.00743	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—RAC1—dilated cardiomyopathy	0.00361	0.00736	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00356	0.00716	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00355	0.00714	CcSEcCtD
Aminosalicylic Acid—PLA2G2E—Metabolism—SDHA—dilated cardiomyopathy	0.00352	0.00718	CbGpPWpGaD
Aminosalicylic Acid—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00352	0.00708	CcSEcCtD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00352	0.00717	CbGpPWpGaD
Aminosalicylic Acid—Anorexia—Lisinopril—dilated cardiomyopathy	0.00345	0.00695	CcSEcCtD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00343	0.00699	CbGpPWpGaD
Aminosalicylic Acid—CHUK—FoxO family signaling—FASLG—dilated cardiomyopathy	0.00338	0.00688	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Furosemide—dilated cardiomyopathy	0.0033	0.00665	CcSEcCtD
Aminosalicylic Acid—CHUK—IL-4 Signaling Pathway—RPS6KB1—dilated cardiomyopathy	0.00327	0.00667	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Furosemide—dilated cardiomyopathy	0.00319	0.00642	CcSEcCtD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—TNF—dilated cardiomyopathy	0.00316	0.00643	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00315	0.00634	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00313	0.00629	CcSEcCtD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—ITGB1—dilated cardiomyopathy	0.00309	0.0063	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Furosemide—dilated cardiomyopathy	0.00307	0.00618	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.00304	0.0062	CbGpPWpGaD
Aminosalicylic Acid—Rash—Furosemide—dilated cardiomyopathy	0.00304	0.00612	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Furosemide—dilated cardiomyopathy	0.00304	0.00612	CcSEcCtD
Aminosalicylic Acid—Headache—Furosemide—dilated cardiomyopathy	0.00302	0.00609	CcSEcCtD
Aminosalicylic Acid—CHUK—Validated transcriptional targets of TAp63 isoforms—FAS—dilated cardiomyopathy	0.00301	0.00614	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00296	0.00596	CcSEcCtD
Aminosalicylic Acid—CHUK—RANKL/RANK Signaling Pathway—RAC1—dilated cardiomyopathy	0.00291	0.00593	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—RAC1—dilated cardiomyopathy	0.00291	0.00593	CbGpPWpGaD
Aminosalicylic Acid—Urticaria—Lisinopril—dilated cardiomyopathy	0.00288	0.00579	CcSEcCtD
Aminosalicylic Acid—Nausea—Furosemide—dilated cardiomyopathy	0.00287	0.00577	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00286	0.00576	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00286	0.00576	CcSEcCtD
Aminosalicylic Acid—CHUK—Class I PI3K signaling events mediated by Akt—RAF1—dilated cardiomyopathy	0.00277	0.00565	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00267	0.00537	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.00257	0.00523	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00256	0.00521	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PDGF Pathway—RAF1—dilated cardiomyopathy	0.00254	0.00518	CbGpPWpGaD
Aminosalicylic Acid—CHUK—EBV LMP1 signaling—TNF—dilated cardiomyopathy	0.00253	0.00516	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Canonical NF-kappaB pathway—TNF—dilated cardiomyopathy	0.00253	0.00516	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—RAC1—dilated cardiomyopathy	0.00252	0.00513	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00252	0.00512	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BCR signaling pathway—RAC1—dilated cardiomyopathy	0.00249	0.00507	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—RAC1—dilated cardiomyopathy	0.00249	0.00507	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00248	0.00499	CcSEcCtD
Aminosalicylic Acid—MPO—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.00244	0.00498	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—RAC1—dilated cardiomyopathy	0.00243	0.00495	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—RAF1—dilated cardiomyopathy	0.0024	0.00488	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Lisinopril—dilated cardiomyopathy	0.0024	0.00482	CcSEcCtD
Aminosalicylic Acid—CHUK—Interleukin-11 Signaling Pathway—RAF1—dilated cardiomyopathy	0.00231	0.0047	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Lisinopril—dilated cardiomyopathy	0.0023	0.00463	CcSEcCtD
Aminosalicylic Acid—Rash—Lisinopril—dilated cardiomyopathy	0.00228	0.0046	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00228	0.00459	CcSEcCtD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—RAC1—dilated cardiomyopathy	0.00227	0.00463	CbGpPWpGaD
Aminosalicylic Acid—Headache—Lisinopril—dilated cardiomyopathy	0.00227	0.00457	CcSEcCtD
Aminosalicylic Acid—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.0022	0.00449	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—FASLG—dilated cardiomyopathy	0.0022	0.00447	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Lisinopril—dilated cardiomyopathy	0.00215	0.00433	CcSEcCtD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00215	0.00438	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—FAS—dilated cardiomyopathy	0.00212	0.00431	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00211	0.0043	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00209	0.00426	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00208	0.00425	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—RAC1—dilated cardiomyopathy	0.00208	0.00423	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00203	0.00413	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—CD36—dilated cardiomyopathy	0.00201	0.0041	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.002	0.00408	CbGpPWpGaD
Aminosalicylic Acid—MPO—Folate Metabolism—TNF—dilated cardiomyopathy	0.00199	0.00405	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—AGT—dilated cardiomyopathy	0.00198	0.00404	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.00197	0.00401	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—RAF1—dilated cardiomyopathy	0.00193	0.00393	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—RAC1—dilated cardiomyopathy	0.00193	0.00393	CbGpPWpGaD
Aminosalicylic Acid—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—dilated cardiomyopathy	0.0019	0.00387	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00188	0.00384	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—RAC1—dilated cardiomyopathy	0.00185	0.00377	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc-epsilon receptor I signaling in mast cells—RAF1—dilated cardiomyopathy	0.00178	0.00362	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—RAC1—dilated cardiomyopathy	0.00178	0.00362	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00175	0.00356	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—CD36—dilated cardiomyopathy	0.00174	0.00354	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.0017	0.00347	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—RAF1—dilated cardiomyopathy	0.00167	0.0034	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.00165	0.00337	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BCR signaling pathway—RAF1—dilated cardiomyopathy	0.00165	0.00336	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—dilated cardiomyopathy	0.00164	0.00335	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—CD36—dilated cardiomyopathy	0.00163	0.00333	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00163	0.00331	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ANKRD1—dilated cardiomyopathy	0.00162	0.00331	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00158	0.00322	CbGpPWpGaD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00158	0.00322	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—TNF—dilated cardiomyopathy	0.00156	0.00319	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PSEN2—dilated cardiomyopathy	0.00155	0.00316	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TAZ—dilated cardiomyopathy	0.00153	0.00311	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—RAF1—dilated cardiomyopathy	0.00151	0.00307	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00149	0.00304	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00149	0.00304	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00149	0.00303	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—CD36—dilated cardiomyopathy	0.00146	0.00297	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF receptor signaling pathway —TNF—dilated cardiomyopathy	0.00145	0.00296	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—RAC1—dilated cardiomyopathy	0.00139	0.00283	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—SDHA—dilated cardiomyopathy	0.00138	0.00281	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—RAF1—dilated cardiomyopathy	0.00138	0.0028	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—RAC1—dilated cardiomyopathy	0.00137	0.00279	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00135	0.00276	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00135	0.00275	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00132	0.00269	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.0013	0.00265	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.0013	0.00265	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00129	0.00263	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—RAF1—dilated cardiomyopathy	0.00128	0.00261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—TNF—dilated cardiomyopathy	0.00126	0.00257	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00126	0.00256	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.00123	0.0025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—RAF1—dilated cardiomyopathy	0.00123	0.0025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—RAC1—dilated cardiomyopathy	0.00122	0.00248	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00118	0.0024	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.00114	0.00233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—RAC1—dilated cardiomyopathy	0.00114	0.00233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—RAC1—dilated cardiomyopathy	0.00114	0.00233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.00114	0.00232	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—EGFR—dilated cardiomyopathy	0.00113	0.0023	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—RAF1—dilated cardiomyopathy	0.00113	0.00229	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.0011	0.00224	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.00108	0.00219	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—GPX1—dilated cardiomyopathy	0.000957	0.00195	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000937	0.00191	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—CD36—dilated cardiomyopathy	0.000932	0.0019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—EGFR—dilated cardiomyopathy	0.000926	0.00189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	0.000909	0.00185	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000905	0.00184	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TNF—dilated cardiomyopathy	0.000899	0.00183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—dilated cardiomyopathy	0.000899	0.00183	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000894	0.00182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—RAF1—dilated cardiomyopathy	0.00087	0.00177	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000862	0.00176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—RAF1—dilated cardiomyopathy	0.000856	0.00174	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000842	0.00172	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—AGT—dilated cardiomyopathy	0.000839	0.00171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNF—dilated cardiomyopathy	0.000836	0.0017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—EGFR—dilated cardiomyopathy	0.000834	0.0017	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.00082	0.00167	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—RAF1—dilated cardiomyopathy	0.000818	0.00167	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—EGFR—dilated cardiomyopathy	0.000814	0.00166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—RAF1—dilated cardiomyopathy	0.000814	0.00166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—RAF1—dilated cardiomyopathy	0.00081	0.00165	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—EGFR—dilated cardiomyopathy	0.000808	0.00165	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000806	0.00164	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—RAF1—dilated cardiomyopathy	0.000806	0.00164	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—dilated cardiomyopathy	0.000789	0.00161	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—RAC1—dilated cardiomyopathy	0.000779	0.00159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TNF—dilated cardiomyopathy	0.000769	0.00157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—RAF1—dilated cardiomyopathy	0.000758	0.00154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	0.000758	0.00154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	0.000758	0.00154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—RAF1—dilated cardiomyopathy	0.000751	0.00153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.000745	0.00152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—RAF1—dilated cardiomyopathy	0.000741	0.00151	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000739	0.0015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000713	0.00145	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000704	0.00143	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000674	0.00137	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.000671	0.00137	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000662	0.00135	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00065	0.00132	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000646	0.00132	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000637	0.0013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.000624	0.00127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—dilated cardiomyopathy	0.000601	0.00122	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.000599	0.00122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	0.000597	0.00122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	0.00059	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—EGFR—dilated cardiomyopathy	0.000587	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—EGFR—dilated cardiomyopathy	0.000561	0.00114	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000559	0.00114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—EGFR—dilated cardiomyopathy	0.000558	0.00114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.000555	0.00113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—EGFR—dilated cardiomyopathy	0.000553	0.00113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000545	0.00111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000531	0.00108	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	0.000526	0.00107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	0.000525	0.00107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	0.00052	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—EGFR—dilated cardiomyopathy	0.00052	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	0.00052	0.00106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000516	0.00105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—EGFR—dilated cardiomyopathy	0.000515	0.00105	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000513	0.00105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000511	0.00104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—EGFR—dilated cardiomyopathy	0.000508	0.00104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NPPA—dilated cardiomyopathy	0.00049	0.000999	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000489	0.000997	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—EGFR—dilated cardiomyopathy	0.000481	0.00098	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	0.000475	0.000968	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PSEN2—dilated cardiomyopathy	0.000475	0.000968	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD36—dilated cardiomyopathy	0.000471	0.00096	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000466	0.000949	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.00046	0.000938	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000453	0.000922	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—RAC1—dilated cardiomyopathy	0.000444	0.000905	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000427	0.000869	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000426	0.000868	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000423	0.000861	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000406	0.000826	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GPX1—dilated cardiomyopathy	0.000375	0.000764	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CD36—dilated cardiomyopathy	0.000365	0.000744	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000365	0.000744	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000356	0.000725	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000354	0.000722	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000333	0.000678	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—AGT—dilated cardiomyopathy	0.000329	0.00067	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ITGB1—dilated cardiomyopathy	0.000322	0.000656	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00032	0.000653	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000295	0.000602	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000295	0.000602	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—RAF1—dilated cardiomyopathy	0.000295	0.0006	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NPPA—dilated cardiomyopathy	0.000291	0.000592	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00029	0.000591	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.00029	0.00059	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000283	0.000576	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000282	0.000575	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PSEN2—dilated cardiomyopathy	0.000281	0.000573	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000276	0.000562	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000275	0.000559	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD36—dilated cardiomyopathy	0.000275	0.000559	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000266	0.000542	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RAC1—dilated cardiomyopathy	0.000259	0.000527	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000254	0.000518	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RAC1—dilated cardiomyopathy	0.000239	0.000487	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000227	0.000463	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000215	0.000439	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—dilated cardiomyopathy	0.000202	0.000412	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000194	0.000395	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000185	0.000377	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RAF1—dilated cardiomyopathy	0.000172	0.00035	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000167	0.000341	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	0.000163	0.000331	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AGT—dilated cardiomyopathy	0.00016	0.000326	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CD36—dilated cardiomyopathy	0.000158	0.000323	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RAF1—dilated cardiomyopathy	0.000158	0.000323	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AGT—dilated cardiomyopathy	0.000143	0.000291	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RAC1—dilated cardiomyopathy	0.000141	0.000288	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	0.000129	0.000263	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CD36—dilated cardiomyopathy	0.000126	0.000256	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—dilated cardiomyopathy	0.000118	0.00024	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AGT—dilated cardiomyopathy	0.000113	0.000231	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000111	0.000226	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—dilated cardiomyopathy	0.000109	0.000221	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RAF1—dilated cardiomyopathy	9.38e-05	0.000191	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—dilated cardiomyopathy	7.61e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—dilated cardiomyopathy	6.43e-05	0.000131	CbGpPWpGaD
